Table 3.
Correlations between AhR expression and clinicopathological characteristics and RIP140 expression, in the whole cohort and in the lymph node-negative versus lymph node-positive BC sub-groups.
| Whole Cohort (n = 167–302) |
Lymph Node-Negative (n = 91–162) |
Lymph Node-Positive (n = 71–124) |
|
|---|---|---|---|
| Age (diagnosis) | 0.027 | 0.091 | 0.006 |
| Histologic type | −0.061 | −0.122 | 0.043 |
| Tumor size | −0.055 | −0.045 | −0.059 |
| Grade | 0.055 | 0.029 | 0.052 |
| Local recurrence | −0.020 | −0.009 | −0.028 |
| Metastasis | −0.064 | −0.086 | −0.073 |
| Triple negative | −0.045 | −0.103 | 0.038 |
| ER | 0.024 | 0.047 | −0.010 |
| PR | 0.071 | 0.078 | 0.061 |
| HER2 | 0.010 | 0.079 | −0.016 |
| RIP140 | 0.284 *** | 0.256 ** | 0.309 *** |
Spearman Rho correlation coefficients are presented. Correlations were statistically significant for p < 0.01 (**) or p < 0.001 (***).